Topics
Medtech Atomo Diagnostics lands massive COVID-19 deal, closes $30 million raise early ahead of IPO
Rapid blood test startup Atomo Diagnostics is playing its part in the fight against coronavirus, signing a deal with French diagnostics company, NG Biotech, to supply up 2.465 million of its rapid, blood-based COVID-19 tests in 2020. The sale landed as the Sydney-based healthtech venture’s $30 million Initial Public Offer was oversubscribed at 20 cents per… Read more »
